Ovid Therapeutics is pumping the brakes on a planned phase 2 trial for its ROCK2 inhibitor in a type of brain ... hit on the ...
The Galileo Project has released the commissioning data from its first Observatory at Harvard University in a new scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback